Абиратерон Стада 500 Mg

Абиратерон Стада 500 mg is an oral medication containing abiraterone acetate, used in prostate cancer therapy. This EU-manufactured drug supports hormone-sensitive cancer treatment by reducing androgen production. Suitable for patients requiring androgen deprivation therapy.

Abiraterone acetate is primarily used to treat prostate cancer, particularly in cases where cancer has spread or progressed despite other treatments. It works by lowering androgen levels in the body, which can slow the growth of cancer cells. This medication is often prescribed alongside other therapies to enhance effectiveness in managing advanced prostate cancer.

Abiraterone acetate may help reduce symptoms associated with prostate cancer, such as bone pain or urinary issues, by targeting hormone production. Patients often report improved comfort and quality of life during treatment. Common effects include fatigue, joint pain, and fluid retention, which vary by individual.

This medication should be taken exactly as prescribed, typically on an empty stomach. Regular monitoring by a healthcare provider is recommended to assess liver function and overall response. Patients should report any unusual symptoms, such as severe fatigue or swelling, promptly. Avoid grapefruit or grapefruit juice while taking this drug.

Abiraterone acetate may interact with certain medications, including strong CYP3A4 inhibitors or inducers, which can affect its effectiveness. Caution is advised when combining with other drugs metabolized by the liver. Alcohol and herbal supplements should be used cautiously; consult a healthcare provider for guidance.